French spend heavily on devices and analyses:
This article was originally published in Clinica
Executive Summary
Estimates for 2001 indicate that French spending on medical devices and materials used in the private sector and featuring on a list of products reimbursed by the state (formerly known as the TIPS list) increased by 13.8% over 2000. Spending on clinical analyses, meanwhile, was up by 6%. These are among the highest increases within the healthcare service and are likely to mean that there are more cost-containment measures on the horizon.
You may also be interested in...
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.